News

MIT Technology Review3m
The first US hub for experimental medical treatments is coming
Montana just passed a new bill backed by longevity enthusiasts that will enable access to drugs and therapies that are not ...
The Manila Times26m
FDA and Cingulate Aligned with Filing Requirements for New Drug Application for Lead ADHD Asset CTx-1301
Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug ...